@SwiftOnSecurity
The inability or unwillingness of fellow #InfoSec professionals to realistically process the threats & risks of a real, physical, airborne, neurotrophic, vasculitis #virus that has literally thousands of scientific papers written about it and has killed millions never, ever stops blowing up my brain.
If you care about providing perspective as to why #CovidIsNotOver & the danger of #covid19 right now, you might want to boost this plot I’ve annotated and discussed in the #AltText. There’s an important point here about the area under the curve and the damage being done as the #SARS_COV_2#virus continues its evolutionary success story using a globally connected population of uninformed, indifferent, and delusional hosts.
This spiky ball of proteins is highly optimized for one thing: spreading.
Disclaimer: The data in this column come from either mainstream news
media sources or scientific research published in peer-reviewed
journals (each category can be determined by following the links in
the reference section). This column's author acknowledges the cultural
bias of the world scientific community in its belief that the
scientific method is the most viable available alternative for
assessing COVID-19 and its effects in an objective manner through a
structured process of observable and repeatable hypothesis testing.
Summary: A new study finds SARS-CoV-2 directly infects the coronary
vasculature and causes plaque inflammation, which could help explain
why people with COVID-19 have an increased risk for ischemic
cardiovascular complications up to 1 year after infection (see
"COVID-19 Virus Infects Coronary Vasculature" under COVID
Complications).
People with rheumatic disease and a history of a specific type of cold
virus infection called OC43 are at elevated risk for developing long
COVID (see "A Common Cold Might Set Some Up for Long COVID" under
Virology & Epidemiology).
Two scientists who pioneered an underlying technology to harness
fragile genetic material in a way that ultimately resulted in the mRNA
vaccines used to combat the COVID-19 pandemic were named winners of
the Nobel Prize in medicine (see "Pair of Trailblazers of mRNA Vaccine
Science Win Nobel Prize" under Media News).
When used against current strains of COVID-19, Pfizer's antiviral
Paxlovid is less effective at preventing hospitalization or death in
high-risk patients. But when looking at death alone, the antiviral is
still highly effective (see "Paxlovid Weaker Against Current COVID-19
Variants" under Vaccinations, Treatment & Testing).
Average levels of SARS-CoV-2, the virus that causes COVID, being found
in wastewater are down about 5%, compared to last week (see
"Wastewater Data Hint at Possible COVID Decline in Some Areas" under
Virology & Epidemiology).
A panel of independent advisers to the Centers for Disease Control and
Prevention (CDC) will meet next month to make recommendations on
updated COVID-19 vaccines ahead of the fall season (see "CDC Advisers
Set to Vote on Updated COVID Vaccines Next Month" under Policy).
A long-term study indicates a correlation between COVID-19 and lasting
cardiovascular impairment (see "Cardiovascular Assessment up to One
Year After COVID-19 Vaccine–Associated Myocarditis" under COVID
Complications).
Mean weekly cannabis-involved ED visits among all young persons were
higher during the COVID-19 pandemic in 2020, 2021, and 2022 (see
"Cannabis-Involved Emergency Department Visits Among Persons Aged <25
Years Before and During the COVID-19 Pandemic" under COVID
Complications).
As the rollout of the newly formulated COVID-19 booster shot begins in
earnest, many Americans are finding roadblocks (see "Shortages, Cost,
and Frustration: Quest for the New COVID Shot" under Policy).
Relatives of COVID ICU patients demonstrate a range of coping styles
and impact on quality of life (see "Quality of Life and Coping With
Stress in Relatives of Patients in Intensive Care Units During
COVID-19" under COVID Complications).
The biotech Moderna said Wednesday that its first combination vaccine,
which protects against influenza and Covid-19, had succeeded in an
early-stage trial and could be ready to launch as soon as 2025 (see
"Moderna’s Combo Vaccine Moves Towards Late-Stage Trial" under
Vaccines, Treatment & Testing).
The May 11, 2023 termination of the PHE has made it increasingly
difficult to accurately track COVID-19 new cases or fatalities.
However, new variants of concern continue to emerge, with consequent
infections and deaths.
Since the termination of the PHE, data on vaccination rates are no
longer being tracked. The last known US COVID-19 vaccination rates
(May 10, 2023) are as follows: full
vaccination (two initial doses) 69.3%; at least one updated booster
dose: 17% (see "Track Covid-19 in the U.S." under
Vaccines, Treatment & Testing). "Our World in Data" stopped trying to
track US booster rates on August 30, 2022 and shows a flat line since
then.
.
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can subscribe at @PsychResearchBot
A new study has found that people differ in how vulnerable they are to different mutations in emerging variants of #SARS-CoV-2. This is because the variant of SARS-CoV-2 a person was first exposed to determines how well their #immune system responds to different parts of the #virus, and how protected they are against other #variants. #Virology#Covid#sflorg https://www.sflorg.com/2023/10/vi10062301.html
I am functionally incapable of not giving a helpful answer to a question.
I believe this is due to being infected w/ the #Librarians#Virus when I worked at the #science library in college. There was no vaccine at the time. The virus eventually takes over to such a degree that even when asked how to judge the ripeness of a melon by complete strangers a demonstration on the technique & auditory assessment of thumping is inevitable... I’m not a melancholy, I’ve accepted my fate.😜 #Dogs#Humor ish
Some are describing the #Novavax#vaccine having the ability to target the parts of the #virus that stay the same. This is a little misleading since Novavax + #adjuvant and your immune system have no idea what parts of the #spike are going to change in new #variants. 🧵 1/
Upload a file, it will scan for viruses using dozens of scanners, and including running in a few VMs to test install, execution (behavior tab), networking (relations tab), and give a report.
Uses a hash to quickly lookup reports if anyone has done this before with your file (fast).
#Scientists say the use of an antiviral may be fueling the evolution of new #Covid variants by causing mutations in the #virus.
#Molnupiravir, which is also sold under the brand name #Lagevrio, is designed to mutate coronavirus to destruction, but researchers found evidence that the virus can sometimes survive the treatment, leading to mutated versions that occasionally spread to other people.
Novel vaccine includes NIH-funded technology in development since 2004. A trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa. The Phase 1 trial will evaluate a novel vaccine known as VIR-1388 for its safety and ability to induce an HIV-specific
¡Que comience el desmadre! Este es el inicio de mi hilo sobre #EVA y mi lectura de los Evangelios. Ya se verá cómo está conectada una cosa con la otra. #Evangelion es una #serie que me ha acompañado por décadas y la he visto muchas veces: me estoy preparando para verla una vez más. Este hilo se alimentará durante días o tal vez semanas.
La primera cosa es el nombre que comparten el conjunto de obras, y para entender un poco más su etimología… ¡con ustedes!… ¡El #DRAE!
#Ireul es el atacante más abstracto hasta ahora. Es como un #virus autoconsciente que busca a Adam, como todos los demás, pero esta vez NERV parece indefensa porque no puede usar ningún EVA para combatirlo.
Je vous gâte en cette belle matinée avec la #bigbox d'un jeu, #Virus, qui était une sorte de #Descent très light dont la particularité était qu'il utilisait comme textures les images présentes sur votre disque dur. Le pitch, c'est qu'un virus avait attaqué votre PC et qu'il fallait l'en chasser. Quand bien même ce jeu aurait été bon il aurait probablement été sabordé par son nom (qui voudrait acheter un virus ? À part moi je veux dire) mais dieu merci il était assez mauvais. #retrogaming#jv
VIR-1388: Clinical Trial of Preventive HIV Vaccine Begins (scitechdaily.com)
Novel vaccine includes NIH-funded technology in development since 2004. A trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa. The Phase 1 trial will evaluate a novel vaccine known as VIR-1388 for its safety and ability to induce an HIV-specific